Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.

Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24.

2.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

3.

Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial.

McAlindon T, Formica M, LaValley M, Lehmer M, Kabbara K.

Am J Med. 2004 Nov 1;117(9):643-9.

PMID:
15501201
4.

Conducting clinical trials over the internet: feasibility study.

McAlindon T, Formica M, Kabbara K, LaValley M, Lehmer M.

BMJ. 2003 Aug 30;327(7413):484-7. No abstract available.

5.

Treating work stress: an alternative to workers' compensation.

Lehmer M, Bentley A.

J Occup Environ Med. 1997 Jan;39(1):63-7.

PMID:
9029433

Supplemental Content

Loading ...
Support Center